Inspire Medical Systems Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +25.6% | -14.8% | +19.4% | +3.7% | +18.0% | -16.0% | +7.8% | +3.4% | +19.9% | -24.0% | -2.0% | – | |
| – | +15.1% | -11.8% | +20.5% | +8.6% | +11.1% | -14.7% | +12.9% | -8.4% | +13.5% | -23.3% | +5.2% | – | |
| – | +27.6% | -15.3% | +19.2% | +2.9% | +19.3% | -16.3% | +6.9% | +5.7% | +20.9% | -24.1% | -3.1% | – | |
| – | +6.5% | -7.1% | +0.0% | -9.6% | +16.3% | -8.3% | -5.7% | -7.6% | +3.0% | +3.5% | -4.4% | – | |
| – | +11.8% | +1.9% | +8.9% | -1.6% | +10.8% | +3.9% | +9.3% | -9.2% | +32.2% | -6.0% | -3.2% | – | |
| – | +9.0% | -0.4% | +4.2% | -2.8% | +9.8% | +0.1% | +7.9% | -1.4% | +2.1% | -4.7% | -3.4% | – | |
| – | – | -263.7% | – | +180.8% | +122.7% | -104.7% | – | – | +378.1% | -102.4% | – | – | |
| – | – | – | – | – | – | – | – | +175.0% | +1,009.1% | – | – | – | |
| – | – | -161.4% | – | +87.4% | +80.2% | -88.6% | -156.1% | – | +271.3% | -95.2% | +30.0% | – | |
| – | +40.3% | +36.3% | +62.0% | +73.7% | -22.8% | -17.4% | +8.0% | +187.2% | -2,470.0% | – | -79.5% | – | |
| – | – | -167.8% | – | +88.9% | +90.4% | -91.5% | -220.1% | – | +1,270.2% | -108.3% | – | – | |
| – | – | -153.0% | – | +81.3% | +155.9% | -87.3% | -84.9% | +1,487.4% | +214.8% | -86.2% | -45.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.